Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 5/2019

01-09-2019 | Distal Radius Fracture | Original Article

Altered gene and protein expressions of vitamin D receptor in skeletal muscle in sarcopenic patients who sustained distal radius fractures

Authors: Young Hak Roh, Seok Woo Hong, Seok Won Chung, Yong-Soo Lee

Published in: Journal of Bone and Mineral Metabolism | Issue 5/2019

Login to get access

Abstract

Despite the presence of vitamin D receptor (VDR) in skeletal muscle cells, the relationship between VDR expressions and muscle mass or function has not been well studied. The purpose of this study was to compare VDR gene and protein expression in the forearm muscle between sarcopenic and non-sarcopenic individuals who have sustained distal radius fractures. Twenty samples of muscle tissue from sarcopenic patients (mean age 63.4 ± 8.1 years) and 20 age- and sex-matched control tissues (62.1 ± 7.9 years) were acquired from the edge of dissected pronator quadratus muscle during surgery for distal radius fractures. The mRNA expression levels of VDR as well as the myokines of interest that may be associated with muscle mass change (myogenin and myostatin) were analyzed with real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). In addition, Western blot assay and immunohistochemistry for VDR were performed. Sarcopenic patients showed a significantly lower level of gene expression for VDR and myogenin, but a greater level of gene expression for myostatin than the controls according to qRT-PCR analysis. The density of VDR protein expressions was 2.1 times greater, while that of myostatin was 2.6 times lower, in the control group than in the sarcopenic group according to Western blot analysis. On immunohistochemical analysis, the density of the cells expressing VDR was significantly decreased in the sarcopenic patients. Sarcopenic patients who sustained distal radius fractures presented lower vitamin D receptor gene and protein expression in skeletal muscles compared to non-sarcopenic individuals.
Literature
1.
Candow DG, Chilibeck PD (2005) Differences in size, strength, and power of upper and lower body muscle groups in young and older men. J Gerontol A Biol Sci Med Sci 60:148–156CrossRefPubMed
2.
Clynes MA, Edwards MH, Buehring B, Dennison EM, Binkley N, Cooper C (2015) Definitions of sarcopenia: associations with previous falls and fracture in a population sample. Calcif Tissue Int 97:445–452CrossRefPubMedPubMedCentral
3.
Trombetti A, Reid KF, Hars M, Herrmann FR, Pasha E, Phillips EM, Fielding RA (2016) Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int 27:463–471CrossRefPubMed
4.
von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle 1:129–133CrossRef
5.
Melton LJ 3rd, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM, Riggs BL (2000) Epidemiology of sarcopenia. J Am Geriatr Soc 48:625–630CrossRefPubMed
6.
Bokshan SL, DePasse JM, Daniels AH (2016) Sarcopenia in orthopedic surgery. Orthopedics 39:e295–e300CrossRefPubMed
7.
Hong W, Cheng Q, Zhu X, Zhu H, Li H, Zhang X, Zheng S, Du Y, Tang W, Xue S, Ye Z (2015) Prevalence of sarcopenia and its relationship with sites of fragility fractures in elderly Chinese men and women. PLoS ONE 10:e0138102CrossRefPubMedPubMedCentral
8.
9.
MacIntyre NJ, Dewan N (2016) Epidemiology of distal radius fractures and factors predicting risk and prognosis. J Hand Ther 29:136–145CrossRefPubMed
10.
Koval KJ, Harrast JJ, Anglen JO, Weinstein JN (2008) Fractures of the distal part of the radius. The evolution of practice over time. Where’s the evidence? J Bone Jt Surg Am 90:1855–1861CrossRef
11.
Jang WY, Chung MS, Baek GH, Song CH, Cho HE, Gong HS (2012) Vitamin D levels in post-menopausal Korean women with a distal radius fracture. Injury 43:237–241CrossRefPubMed
12.
Roh YH, Koh YD, Noh JH, Gong HS, Baek GH (2017) Evaluation of sarcopenia in patients with distal radius fractures. Arch Osteoporos 12:5CrossRefPubMed
13.
Owen RA, Melton LJ 3rd, Ilstrup DM, Johnson KA, Riggs BL (1982) Colles’ fracture and subsequent hip fracture risk. Clin Orthop Relat Res 37–43
14.
Visser M, Deeg DJH, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88:5766–5772CrossRefPubMed
15.
Snijder MB, van Schoor NM, Pluijm SMF, van Dam RM, Visser M, Lips P (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980–2985CrossRefPubMed
16.
Bouillon R, Gielen E, Vanderschueren D (2014) Vitamin D receptor and vitamin D action in muscle. Endocrinology 155:3210–3213CrossRefPubMed
17.
Girgis CM, Mokbel N, Cha KM, Houweling PJ, Abboud M, Fraser DR, Mason RS, Clifton-Bligh RJ, Gunton JE (2014) The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 155:3227–3237CrossRefPubMedPubMedCentral
18.
19.
Pojednic RM, Ceglia L, Olsson K, Gustafsson T, Lichtenstein AH, Dawson-Hughes B, Fielding RA (2015) Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Calcif Tissue Int 96:256–263CrossRefPubMed
20.
Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19:265–269CrossRefPubMed
21.
Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE (2013) The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 34:33–83CrossRefPubMed
22.
Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia. J Am Med Dir Assoc 15:95–101CrossRefPubMed
23.
24.
O’Sullivan LW, Gallwey TJ (2005) Forearm torque strengths and discomfort profiles in pronation and supination. Ergonomics 48:703–721CrossRefPubMed
25.
Demontis F, Piccirillo R, Goldberg AL, Perrimon N (2013) The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12:943–949CrossRefPubMed
26.
Roubenoff R, Hughes VA (2000) Sarcopenia current concepts. J Gerontol Ser A 55:M716–M724CrossRef
27.
Kunihiro S, Akihiko Y (2010) Molecular mechanisms in aging and current strategies to counteract sarcopenia. Curr Aging Sci 3:90–101CrossRef
28.
Zhou J, Freeman TA, Ahmad F, Shang X, Mangano E, Gao E, Farber J, Wang Y, Ma X-L, Woodgett J, Vagnozzi RJ, Lal H, Force T (2013) GSK-3α is a central regulator of age-related pathologies in mice. J Clin Investig 123:1821–1832CrossRefPubMed
29.
Kunihiro S, Akihiko Y (2012) Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass. J Cachexia Sarcopenia Muscle 3:77–94CrossRef
30.
Wohlgemuth SE, Seo AY, Marzetti E, Lees HA, Leeuwenburgh C (2010) Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 45:138–148CrossRefPubMed
31.
McKay BR, Ogborn DI, Bellamy LM, Tarnopolsky MA, Parise G (2012) Myostatin is associated with age-related human muscle stem cell dysfunction. FASEB J 26:2509–2521CrossRefPubMed
32.
Kim JS, Kosek DJ, Petrella JK, Cross JM, Bamman MM (2005) Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women. J Appl Physiol (1985) 99:2149–2158CrossRef
33.
34.
Alway SE, Lowe DA, Chen KD (2001) The effects of age and hindlimb suspension on the levels of expression of the myogenic regulatory factors MyoD and myogenin in rat fast and slow skeletal muscles. Exp Physiol 86:509–517CrossRefPubMed
35.
36.
Laurent MR, Dubois V, Claessens F, Verschueren SM, Vanderschueren D, Gielen E, Jardi F (2016) Muscle-bone interactions: from experimental models to the clinic? A critical update. Mol Cell Endocrinol 432:14–36CrossRefPubMed
37.
38.
Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10:56–63PubMedPubMedCentral
39.
Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007) Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 104:1835–1840CrossRefPubMed
40.
41.
Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF (2002) Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting. J Nutr Health Aging 6:343–348PubMed
42.
Simpson RU, Thomas GA, Arnold AJ (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260:8882–8891PubMed
43.
Horst RL, Goff JP, Reinhardt TA (1990) Advancing age results in reduction of intestinal and bone 1,25-dihydroxyvitamin D receptor. Endocrinology 126:1053–1057CrossRefPubMed
44.
Girgis CM, Cha KM, Houweling PJ, Rao R, Mokbel N, Lin M, Clifton-Bligh RJ, Gunton JE (2015) Vitamin D receptor ablation and vitamin D deficiency result in reduced grip strength, altered muscle fibers, and increased myostatin in mice. Calcif Tissue Int 97:602–610CrossRefPubMed
45.
Garcia LA, King KK, Ferrini MG, Norris KC, Artaza JN (2011) 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152:2976–2986CrossRefPubMedPubMedCentral
46.
Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, Kato S, Matsumoto T (2003) Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 144:5138–5144CrossRefPubMed
47.
Kim K, Gong HS, Lim JY, Kim JH, Baek GH (2018) The vitamin D receptor expression in skeletal muscle of women with distal radius fracture. Arch Osteoporos 13:24CrossRefPubMed
48.
Srikuea R, Zhang X, Park-Sarge OK, Esser KA (2012) VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303:C396–C405CrossRefPubMedPubMedCentral
49.
Tanaka M, Kishimoto KN, Okuno H, Saito H, Itoi E (2014) Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines. Muscle Nerve 49:700–708CrossRefPubMed
50.
Girgis CM, Clifton-Bligh RJ, Mokbel N, Cheng K, Gunton JE (2014) Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155:347–357CrossRefPubMed
Metadata
Title
Altered gene and protein expressions of vitamin D receptor in skeletal muscle in sarcopenic patients who sustained distal radius fractures
Authors
Young Hak Roh
Seok Woo Hong
Seok Won Chung
Yong-Soo Lee
Publication date
01-09-2019
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 5/2019
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-019-00995-0

Other articles of this Issue 5/2019

Journal of Bone and Mineral Metabolism 5/2019 Go to the issue

Original Article

Accumulation of microdamage in subchondral bone at the femoral head in patients with end-stage osteoarthritis of the hip

Original Article

Predicting radiological vertebral fractures with a combined physical function and body composition scoring system

Original Article

Metabolic characteristics of subjects with spine–femur bone mineral density discordances: the Korean National Health and Nutrition Examination Survey (KNHANES 2008–2011)

Original Article

ALPL mutations in adults with rheumatologic disorders and low serum alkaline phosphatase activity

Original Article

Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw

Original Article

Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits